OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Charity Registration No. 1158843 (England & Wales) Scottish Charity No. SC050277

Company Registration No. 08644039 (England and Wales)

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

TRUSTEES’ REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Mr M Cawley (resigned 17/12/20) Mr R J Harris Mr N Randle Mr M Stock Professor H Cheyne (Appointed 1/5/20) Dr R Watson (Appointed 1/5/20) Mr A Gilmour (Appointed 1/5/20) Ms T Thorne (appointed 24/2/21) Dr E Hozefa (Appointed 1/5/20) Charity number 1158843 Company number 08644039 Registered office First Floor International House 20 Hatherton Street Walsall WS4 2LA Auditor Azets Audit Services International House 20 Hatherton Street Walsall WS4 2LA

2

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

CONTENTS
Page
Trustees' Report 4 – 12
Independent Auditors’ Report 13 –16
Consolidated Statement of Financial Activities 17
Consolidated Balance Sheet 18
Charity Balance Sheet 19
Consolidated Statement of Cash Flows 20
Notes to the Financial Statements 21 – 32

3

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT)

The Trustees present their annual report together with the audited financial statements of the group and the charity for the year 1 April 2020 to 31 March 2021. The Trustees confirm that the annual report and financial statements of the charity comply with the current statutory requirements, the requirements of the charity's governing document and the provisions of the Statement of Recommended Practice (SORP), applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) as amended by Update Bulletin 2 (effective 1 January 2019).

The group consists of the United Kingdom Sepsis Trust Limited (also referred to as 'parent charity', 'charity' or 'charitable company') and its wholly owned subsidiary, Sepsis Enterprises Limited.

Since the charity and the group qualifies as small under section 383, the strategic report required of medium and large companies under The Companies Act 2006 (Strategic Report and Director's Report) Regulations 2013 is not required.

Objectives and activities

a. Policies and objectives

The organisation is a charitable company, registered with the Charities Commission on 10 October 2014 and incorporated on 8 August 2013. The charity is constituted under its Memorandum and Articles of Association dated 5 August 2013. The Articles of Association were updated on the 14 January 2020.

At the start of the financial year, the Trustee Board consisted of Mark Stock (Chairman), Richard Harris, Nick Randle & Mark Cawley. Additional Trustees were appointed in year, Professor Helen Cheyne, Alan Gilmour, Robert Watson & Dr Hozefa Ebrahim jointed the Board on 1 May 2020, with Ms Tiffany Thorne joining the board on the 24 Feb 2021. Mr Mark Cawley left the board on 17 Dec 2020. Dr Darren Daniels (Founder and Executive Director – Clinical) jointly leads the organisation with Sarah HamiltonFairley, Executive Director – Strategy & Development.

4

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

Public benefit statement

The Trustees confirm that they have had due regard for the Charity Commission Guidance on public benefit when reviewing the charity’s aims and objectives, planning future strategy and setting policy. The work of UKST is fundamental in reducing the number of unnecessary deaths per year from sepsis and supporting those who have been affected by the condition.

Aims and activities

In line with our objects, the charity's main activities, which are all in relation to our purposes for public benefit, are:

Educating healthcare professionals, health commissioners, government organisations and the wider public to ‘think’ sepsis (and severe infection), recognise the condition swiftly, and ensure that it is treated as an emergency, whilst maintaining a responsible stance on the use of antimicrobials;

Providing support to patients and their relatives, including those bereaved by sepsis, through the provision of accessible information and the development of support networks; and

Lobbying the Government to ensure that the infrastructure to support hospitals and other healthcare organisations in delivering exemplary sepsis care is in place.

b. Strategies for achieving objectives

Education and Training

The charity continued to maintain good relationships with Royal Colleges and the NHS Cross System Programme Board on Sepsis. It is noted that challenges have emerged, as outcomes from sepsis have improved through earlier interventions and perceptions around pathways driving the use of antibiotics are evolving. Next year, as the Programme Board develops into the NHS Deterioration Board, UKST will continue to push to maintain sepsis as a clinical priority whilst ensuring a responsible approach to antimicrobial usage.

Our ‘Train the Trainer’ programme was placed on hold during the year, due to the government restrictions surrounding COVID-19. We continue to build the concept of disseminated learning using regional coordinators and volunteer educators.

The revised strategy will place online resources as the top priority. UKST has developed five e-learning modules for health professionals and care workers over the last two years. These have been accessed and completed by 7,369 health professionals in the period. Work continues to take place to provide more on line digital education tools in the future.

Support Helpline

The charity helpline provides information and support for anyone affected by sepsis. The service is delivered by our paid nursing support team – all of whom have considerable experience in caring for patients with sepsis and critical illness. All nurses are registered with the NMC and meet their revalidation criteria, enabling them to stay qualified, supported and develop professionally. During the year work was carried out to improve the helpline service, with the result that calls are now answered directly by a support nurse rather than a 3rd party call handling service.

5

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

Support group network

Meeting other survivors and having the opportunity to share experiences can be tremendously helpful – we provide the facility to do this via our sepsis support groups. These are relaxed, informal sessions and work on a model of peer support. By sharing personal experiences people learn that they are not alone and feedback indicates that they appreciate the social interaction and emotional assistance. The groups are Co-led by a sepsis nurse and a survivor volunteer.

Due to COVID-19, our face to face groups were suspended in March 2020 and were replaced by online sessions. These were delivered via the Zoom platform on a weekly basis and appear to be well received. The plan at the time of writing is to continue these, alongside our face-to-face sessions, as they allow us to reach people who don’t live near to a group and/or people who find it difficult to get out of the house.

Information

We are continuously updating and developing new resources which are accessible on the UKST website. We have an established process for reviewing our website content to ensure it provides current and relevant information on sepsis and sepsis recovery. During the year we created a new recovery diary to aid and assist those recovering from sepsis and critical illness.

COVID-19 response

A significant number of people admitted to hospital with COVID-19 will have been in critical care and many of these patients require ongoing support for physical, emotional and cognitive problems. As the UKST support nurses have experience of helping people recovering from critical illness the charity stepped up to extend these transferable skills to support patients who are recovering from COVID-19. We undertook this in several ways.

A National Long COVID Recovery Programme

Working in partnership with Maximus UK, and drawing on our shared experience of working with survivors of sepsis, there is strong evidence that access to trusted information and guidance after critical illness is a vital part of the recovery and rehabilitation process. We therefore developed a proposal which describes a practical, scalable, and digitally enabled national recovery service for survivors of Covid-19 and/or sepsis and those living with Long Covid and post-sepsis syndrome. We are currently, proactively looking for investors/partners to fund the development of this service.

Networks more widely

Over the year we’ve developed stronger and closer relationships with our five specialist law firm partners. The lock-down periods allowed us to meet more frequently, albeit via Zoom, which resulted in closer understanding and communication between us all. The production of specific videos explaining different aspects of the services law firms offer is a welcome addition to UKST’s website and the same goes for the information leaflets. The charity is extremely grateful for their loyal and ongoing support financially, but also for the significant ‘in kind’ pro bono support UKST receives throughout the year.

UKST would also like to extend sincere thanks to the Development Group members, chaired by Lord Grade. Its ongoing commitment has been most productive and is much appreciated. We intend, as time permits, to set up similar, regional, Development Groups across the country.

6

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

Fundraising and other income Community fundraising

Disappointingly, but unsurprisingly, COVID-19 put the majority of the charity’s forthcoming traditional community fundraising plans and activities in this area on hold. Having said that, donations from community fundraising activity continued to be an important source of income for the charity. UKST developed a robust plan to increase donations from a number of distinct revenue streams, such as third-party events, regular giving and legacy, within our community fundraising programme.

Other Income

We were delighted to be successful in our bid to Bridgepoint’s Hardship Fund which resulted in UKST receiving £75,000. We were also delighted to learn, in late spring that our application to both the Direct Line Group (£95,000), the Coronavirus Community Support Fund (£100,000) and The Leathersellers’ Company (£20,000) had been granted. We are also most grateful to Lord Ashcroft for his on-going support (£50,000).

Iceland Foods Charitable Foundation (IFCF) and Iceland Foods deserve special mention as they continued to support both financially and ‘in kind’ – by printing messaging on their milk cartons. Towards the end of this year we celebrated the latter when the carton distribution hit 100 million! IFCF are lead partner in our Sepsis Savvy Campaign which encourages businesses to raise awareness of sepsis among their staff, customers and clients. Iceland Foods were one of the first organisations to sign up to Sepsis Savvy. Their on-going commitment to the cause is inspirational and of course, much appreciated.

Public Awareness via Communications, Media & PR

Awareness Campaigns

There were two awareness campaigns during the year. The first was Blurred Lines which focussed on the similarities between COVID-19 and sepsis, the second was Sepsis Savvy (see under narrative around Iceland above).

In April 2020 we received a one month £100K Twitter advertising budget donated by Group M, which resulted in 5,000 new followers. We used the budget for our Blurred Lines campaign to highlight the links between COVID-19 and sepsis. As well as across Twitter, the advert was featured in print in The Times, The Daily Mail, Metro, and also appeared in web adverts on Harper’s Bazaar, Cosmopolitan, Runner’s World and Digital Spy’s websites, amongst others.

Over a 13 day period in July, these adverts also appeared on 56 digital screens in London, Birmingham, Edinburgh and Glasgow. A potential 9 million people saw the adverts, which had a financial value of £365K. The charity is extremely grateful to Group M for securing such significant pro-bono advertising.

Our total media exposure for the year was up 103% (including social and traditional media). This year, ‘The UK Sepsis Trust’ charity was mentioned 1.4bn times in global media, and ‘Sepsis’ was mentioned 4.3bn times in UK media, and 30bn times in global media. Dr Ron Daniels featured heavily on both national and international television and radio broadcasts discussing COVID-19 and its links with sepsis. Programmes included Channel 4 News, This Morning, Sky News, CNN News, Victoria Derbyshire, and radio broadcasts included BBC Wales, Times Radio and BBC West Midlands.

7

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

This year, our social media presence has grown significantly, and has become a more prominent focus. On Facebook, our reach (number of times people saw our content) was 2,042,270, with 118,528 on Instagram (an increase of 302.5%).

Our followings have grown by: 1,635 on Facebook – total following 39,779

5,360 on Twitter – total following 26,944

1,100 on Instagram – total following 6,191

Facebook and Instagram’s business analytic suite has allowed us to better understand our audience across the two platforms. People who identify as women, aged between 25 and 44 were by far our biggest demographic, accounting for 87% of our followers on Facebook and 83% on Instagram. Aside from London being the most common location, the rest of our followers are predominantly based in the North of England, Scotland and Wales.

Our social media work has also led to an increase in the number of sepsis articles in traditional media. Case studies are by far our most popular posts (in terms of engagement and likes), and have resulted in local newspapers and radio stations contacting the Trust to interview or report on people’s stories. An example of this is David Cram’s story, which was seen by 120.9K people on social media alone – our most popular post of the year. He was interviewed by The Mirror as well as other local papers in the North West as a result.

Volunteer network

It will come as no surprise to read that it has been a challenging year for the volunteer network and volunteering more generally. We have been experiencing the anticipated decline in our volunteer engagement as our community awareness and events related activities came to an abrupt stand-still in March 2020.

Between April 2020 and March 2021, we have been engaging with our volunteers on a 100% remote basis. This was obviously a new and difficult challenge, but working closely with our support and senior leadership teams, our volunteer manager managed to deliver our key charitable objectives via a radically re-designed online volunteer programme.

Specifically, over this period:

It is our ambition over the next 12 months to increase our active volunteer engagement to a level the charity was experiencing before the pandemic. We are also aiming to deliver a community engagement programme to support our Sepsis Savvy campaign and community awareness aims.

We would like to thank all our volunteers – many of whom have been affected by sepsis – for their loyalty, ongoing hard work and commitment throughout this turbulent and challenging time.

8

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

Wales

UKST continues to be the third sector ‘sepsis authority’ in Wales. While the charity enjoys excellent engagement with healthcare, government and volunteers this has, of course, been seriously impacted by COVID-19 this year.

Support from the Welsh Assembly Government Cross Party Group on Sepsis remained strong and its final report was submitted ahead of the election. The charity continues to lobby for a public awareness campaign and will continue to work on this with the new cabinet and new Health Secretary Eluned Morgan. The outgoing Health and Social Services Committee has also recommended that the inquiry into Sepsis should continue during the next Senedd having been postponed this year due to the pandemic. We aim to keep the pressure on in this area over the coming months to ensure we remain on the agenda.

UKST sits on two Public Health Wales (PHW) steering groups and are partners on ‘Project Sepsis’ with Cardiff University and University Hospital of Wales and with Welsh Ambulance on the PhRASe2 project. We are also introducing these institutions to ‘Sepsis Savvy’. It has been important to maintain these partners and relationships for when COVID-19 settles down and we have already started to see an increase in interest for sepsis education awareness from health professionals. This bodes well for the coming year as re-engaging with grass root professionals is a key objective.

UKST has continued to work hard in Wales to expand its reach with both current, new audiences and networks. As well as partnering with our traditional community groups such St John Ambulance, there has been a particular focus on under-served communities which were highlighted as being potentially at higher risk of infection during the pandemic. To this end we have developed a relationship with Cardiff Council and are working with their network heads (BAME, disability, Women, LGBT+ Carers) on developing ways of introducing sepsis education and awareness. The aim is to develop a model based around ‘Sepsis Savvy’ which can then be used as a ‘template’ for other councils and networks.

We have maintained our partnership with Cardiff University and developed further relationships with Bangor University and University of South Wales. Though restrictions have not permitted visits, we have still managed to deliver several sepsis presentations to nursing and medical students online.

Prior to the pandemic we had two established support groups and were working with Public Health Wales to expand regionally. While face-to-face groups have not been possible, with the help of our support team, we have been able to make more frequent and accessible groups available online.

While it has been a difficult year for community fundraising, we managed to engage our Welsh fundraisers and some local health boards in our successful virtual event ‘Cycle4Sepsis’.

While COVID-19 has dominated the news over the past year, we do continue to maintain a cross platform media presence when appropriate and ITV Wales are currently working on a one hour documentary on sepsis to be aired later in the year.

Scotland

As of July 10 2020, the office of the Scottish Charity Regulator (OSCR) awarded UKST charitable status in Scotland. Due to the impact and related restrictions of COVID-19 we have not been able to establish our presence as much as we would have liked. We have however used our time over the past year to build some key relationships and to develop our awareness materials and new initiatives such as ‘Sepsis Savvy’. This, combined with the addition of a health professional (who is also a sepsis survivor) to the Trustee Board, will help us with our strategy and presence in Scotland moving forward.

9

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

Achievements and performance

a. Key financial performance indicators

2020–2021 was another challenging year with income, whilst finishing head of the budgeted target, being significantly reduced – (approximately 43%) on the previous year as a result of the Covid pandemic.

Opportunities to deliver national and high-profile campaigns became apparent and it required investment to deliver this, putting stress on the income streams.

All income streams have been identified and are reported each month and additional income has been generated from UKST led events, with a plan to increase these during the future years. Weekly cash flow and monthly management & KPI reports are now in place.

A baseline budget has been prepared for the 2021-2022 FY and performance against this will be reported each month. Due to Coronavirus and a reduction of income generation the UKST Board have developed a Task force to ensure a continuous, and regular, review of forecast predictions. The task force has generated three forecast models, Worst Case, Mid Case and Most Likely. These are reviewed in line with the latest forecast expectation on a 12-month rolling cycle.

Financial Review

a. Going Concern

Business operations were impacted from approximately March 2020 onwards due to the COVID-19 pandemic; an event which has continued after the balance sheet date. The UKST was able to draw on previously prepared pandemic and crisis plans, which were implemented accordingly. During this period, UKST took all necessary measures to protect the business and maintain operations as much as possible. Despite the impact of COVID-19, the Trustees believe that UKST can meet its obligations as they fall due for a period of at least 12 months from the date of approval of these financial statements.

b. Reserves policy

The United Kingdom Sepsis Trust Limited is currently dependent on voluntary donations to sustain its activities to continue operating.

This means if there were to be a shortfall in voluntary donations it would put the charity in jeopardy. If serious funding problems were to occur that threatened the existence of the Trust, the Trustees have agreed to keep a certain level of financial reserves to ensure that the core operations can continue for a period of six months.

The current reserves policy represents six months of expenditure which will be monitored on a regular basis and varied accordingly.

10

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

Structure, governance & management

a. Constitution

The charity and the group are registered as a charitable company limited by guarantee which was set up by a Trust deed on 5 August 2013.

The charity and the group are constituted under a Trust deed dated 5 August 2013 with a registered charity number 1158843.

b. Method of appointment or election of trustees

Recruitment of Trustees has occurred as a result of direct interest in the charity. Trustees have been chosen through an analysis of skills to enable the progress of the charity's objects. Trustees induction has occurred through direction from the Charity Commission guidance. Formal induction processes are in place. These are reviewed on a regular basis.

c . Risk management

The Trustees have assessed the major risks to which the charity and the group is exposed, in particular those related to the operations and finances and are satisfied that systems and procedures are in place to mitigate our exposure to the major risks identified.

11

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

TRUSTEES’ REPORT (INCLUDING DIRECTORS’ REPORT) (Continued)

Statement of Trustees’ report responsibilities

The Trustees (who are also Directors of United Kingdom Sepsis Trust Limited for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and the group and of the incoming resources and application of resources, including the income and expenditure, of the charitable group for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company and the group's transactions and disclose with reasonable accuracy at any time the financial position of the charitable group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of information to auditors

Each of the persons who are Trustees at the time when this Trustees' report is approved has confirmed that:

Auditor

The auditors, Azets Audit services, have indicated their willingness to continue in office. The Designated Trustees will review and propose a motion re-appointing the auditors at a meeting of the Trustees.

The Trustees’ report was approved by the Trustees and signed on their behalf by:

Date: 3 November 2021

12

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

INDEPENDENT AUDITORS’S REPORT TO THE MEMBERS OF UNITED KINDGON SEPSIS TRUST LIMITED

Opinion

We have audited the financial statements of United Kingdom Sepsis Trust Limited (the ‘parent charitable company’) and its subsidiaries (the 'group') for the year ended 31st March 2021 which comprise the consolidated Statement of Financial Activities, the consolidated and parent Balance Sheet, the consolidated Statement of Cash Flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group’s or parent charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the Report of the Trustees , other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other

13

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and parent charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement, the trustees (who are also the directors of the parent charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the groups and parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or parent charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed auditor under the Companies Act 2006 and report in accordance with this Act.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a

14

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at:

https://www.frc.org.uk/Our-Work/Audit/Audit-and-assurance/Standards-and-guidance/Standards-andguidance-forauditors/Auditors-responsibilities-for-audit/Description-of-auditors-responsibilities-foraudit.aspx. This description forms part of our auditor’s report.

Extent to which the audit was considered capable of detecting irregularities, including fraud Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud.

We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.

In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

15

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 . Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members, for our audit work, for this report, or for the opinions we have formed.

John Hegney FCCA Senior Statutory Auditor

For and on behalf of

Azets Audit Services Chartered Accountants and Statutory Auditors First Floor International House 20 Hatherton Street Walsall WS4 2LA

Date: 3 November 2021

Azets Audit Services is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006.

16

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT)

Note
Income from:
Donations &
Legacies
2
Charitable Activities
3
Total Income
Expenditure on:
Raising funds
4
Charitable activities
Total Expenditure
5
Other Income:
Corporation Tax
R&D reclaim
Net Income for the
year and net
movement in
funds
Total funds bought
forward
Total funds carried
forward		 Unrestricted
funds
£
Restricted
funds
£
2021 Total
£
1,172,916
140,000
1,312,916
78,331
78,331
1,251,247
140,000
1,391,247
17,812
17,812
1,003,946
100,000
1,103,946
1,021,758
100,000
1,121,758
-
-
-
229,489
40,000
269,489
737,745
-
737,745
967,234
40,000
1,007,234		 2020 Total
£
1,971,740
436,204
2,407,944
307,890
1,901,362
2,209,252
6,258
204,950
532,795
737,745

There was no restricted fund income or expenditure in 2020.

17

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

CONSOLIDATED BALANCE SHEET AS AT 31 MARCH 2021

2021
2020
Notes
£
£
£
Fixed assets
Tangible assets
9
4,748
Current assets
Debtors
12
34,389
63,260
Cash at bank and in hand
1,174,522
1,012,235
1,208,911
1,075,495
Creditors: amounts falling due within
one year
13
(206,425)
(348,663)
Net current assets
1,002,486
Net assets
1,007,234
Charity funds
Restricted funds14
40,000
Unrestricted funds14
967,234
Total funds
1,007,234		 £
10,913
726,832
737,745
-
737,745
737,745

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Trustees and authorised for issue on 3 November 2021 and are signed on its behalf by:

Company Registration No. 08644039

18

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

The notes on pages 21 to 32 form part of these financial statements.

CHARITY BALANCE SHEET AS AT 31 MARCH 2021

2021
2020
Notes
£
£
£
Fixed assets
Tangible assets
9.1
4,748
Investments
10
1
4,749
Current assets
Debtors
12.1
187,549
269,284
Cash at bank and in hand
927,007
774,705
1,114,556
1,043,989
Creditors: amounts falling due within
one year
13.1
(115,463)
(248,114)
Net current assets
999,093
Net assets
1,003,842
Charity funds
Restricted funds
40,000
Unrestricted funds
963,842
Total Funds
1,003,842		 £
10,879
1
10,880
795,875
806,755
-
806,755
806,755

The company’s financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 3 November 2021 and are signed on its behalf by:

19

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

Company Registration No. 08644039

The notes on pages 21 to 31 form part of these financial statements. CONSOLIDATED STATEMENT OF CASH FLOWS

Notes
Cash flows from operating activities
Cash generated from operations
22
Investing activities
Purchase of tangible fixed assets
Net cash used in investing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 2021
£
£
162,287
-
-
162,287
1,012,235
1,174,522		 2020
£
£
450,103
(3,521)
(3,521)
446,582
565,653
1,012,235

The notes on pages 21 to 32 form part of these financial statements.

20

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS

1 Accounting policies

Charity information

United Kingdom Sepsis Trust Limited is a company limited by guarantee incorporated in England and Wales. The registered office is First floor, International House, 20 Heatherton Street, Walsall, WS4 2LA.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2016). The is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in Sterling, which is the functional currency of the group and charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements consolidate the accounts of United Kingdom Sepsis Trust Limited and all of its subsidiary undertakings ('subsidiaries'). No separate Statement of financial activities has been presented for the company as permitted by section 408 of the Companies Act 2006.

The company has taken advantage of the exemption contained within section 408 of the Companies Act 2006 not to present its own Income and expenditure account.

1.2 Going concern

Business operations were impacted from approximately March 2020 onwards due to the COVID-19 pandemic; an event which has continued after the balance sheet date. The Charity was able to draw on previously prepared pandemic and crisis plans, which were implemented accordingly. During this period, the Charity took all necessary measures to protect the business and maintain operations as much as possible. Despite the impact of COVID-19, the directors believe that the Charity can meet its obligations as they fall due for a period of at least 12 months from the date of approval of these financial statements.

1.3 Charitable Funds

Restricted Funds

These are funds that can only be used for particular restricted purposes. Restrictions arise when specified by the donor or when funds are raised for a particular restricted purpose. Unrestricted Funds

These are funds which can be used in accordance with the charitable objects at the discretion of the trustees.

1.4 Incoming resources

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

21

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

1.5 Expenditure

Fundraising costs are those incurred in seeking voluntary contributions and do not include costs of disseminating information in support of the charitable activities.

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

Charitable activities and Governance costs are costs incurred on the company’s operations, including support costs and costs relating to the governance of the company apportioned to charitable activities.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses. All assets costing more than £500 are capitalised.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Office equipment

3 years straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset and is recognised in net income/(expenditure) for the year.

1.7 Impairment of fixed assets

At each reporting end date, the directors review the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

22

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

1.9 Financial Instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic Financial Liabilities

Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

1.10 Employee Benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the is a demonstrable commitment to terminate the employment of an employee or to provide termination benefits.

1.11 Retirement Benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12 Taxation

The company is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the company is potentially exempt from taxation in respect of income or capital gains received within categorises covered by Chapter 3 Part 11 pf the Corporation Tax Act 2010 or section 256 of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

1.13 Fund Accounting

General funds are unrestricted funds which are available for the use at the discretion of the Trustees in furtherance to the general objectives of the company and which have not been designated for other purposes.

23

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

2 Donations and Legacies

Donations & gift aid
Grants, sales of publications & resources		 Unrestricted
funds
Restricted
Funds
Total
2021
2021
2021
£
£
£
1,092,008
40,000
1,132,008
80,908
100,000
180,908
1,172,916
140,000
1,312,916		 Total
2020
£
1,971,740
-
1,971,740

There were no restricted fund donations or legacies in 2020

3 Charitable activities

Charity Charity
incoming incoming
resources resources
2021 2020
£ £
Sales within charitable activities 78,331 436,204
4 Raising funds
Total Total
2021 2020
£ £
Fundraising events 17,812 307,890

All fundraising events in 2021 and 2020 were unrestricted

5 Analysis of expenditure by type

Costs of raising funds
Direct Costs		 Unrestricted
funds
Restricted
Funds
Total
2021
2021
2021
£
£
£
17,812
-
17,812
1,003,946
100,000
1,103,946
1,021,758
100,000
1,121,758		 Total
2020
£
307,890
1,901,362
2,209,252

There was no restricted fund expenditure in 2020

24

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

6 Auditor's remuneration

The Auditor's remuneration amounts to an Audit fee of £13,000 (2020 - £20,000) and other accountancy services of £Nil (2020 - £Nil).

7 Employees

Number of employees

The average number of employees during the year was:

Average number of employees
Employment costs
Wages and salaries
Social security costs
Other pension costs		 2021
2020
No.
No.
18
22
2021
2020
£
£
741,560
933,006
79,052
84,503
15,066
18,806
835,678
1,036,315		 2020
No.
22
2020
£
933,006
84,503
18,806

The number of employees whose employee benefits (excluding employer pension costs) exceeding £60,000 Was:

In the band £60,001 to £70,000
In the band £80,001 to £90,000
In the band £100,001 to £110,000		 2021
No.
-
1
1
2		 2020
No.
2
-
-
2

25

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

8 Taxation

The parent charity is exempt from corporation tax and all of it’s income is charitable and is applied for charitable purposes. The trading subsidiary, Sepsis Enterprises Limited, donates all taxable profits to the parent charity.

Factors affecting future tax charges

The trading subsidiary, Sepsis Enterprises Limited has trading losses carried forward of £2,859 (2020 - £75,296).

The trading company incurred losses in previous years and therefore no corporation tax is attributable.

During the financial year, the trading subsidiary, Sepsis Enterprises Limited, received an R&D tax refund of £Nil (2020 - £6,258).

9 Tangible fixed assets

Office
Equipment
Group £
Cost
At 1 April 2020 30,524
Disposals (12,809)
At 31 March 2021 17,715
Depreciation
At 1 April 2020 19,611
Depreciation charged in the year 6,165
Eliminated in respect of disposals (12,809)
At 31 March 2021 12,967
Carrying amount
At 31 March 2021 4,748
At 31 March 2020 10,913

26

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

9.1
Tangible fixed assets
Company
Cost
At 1 April 2020
Additions
Disposals
At 31 March 2021
Depreciation
At 1 April 2020
Depreciation charged in the year
Eliminated in respect of disposals
At 31 March 2021
Carrying amount
At 31 March 2021
At 31 March 2020
10
Fixed asset investments
Fixed Asset investments
21
Movements in fixed asset investments
Cost
At 1 April 2020 & 31 March 2021
Carrying amount
At 31 March 2021
At 31 March 2020		 Office
Equipment
£
27,485
-
(9,769)
17,716
16,606
6,131
(9,769)
12,968
4,748
10,879
2021
2020
£
£
1
1
Shares in
group
undertakings
£
1
1
1

27

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

11 Financial instruments group 2021 2020
£ £
Carrying amount of financial assets
Debt instruments measured at amortised cost 1,199,120 1,056,624
Carrying amount of financial liabilities
Measured at amortised cost 172,983 327,493
11.1 Financial instruments company 2021 2020
£ £
Carrying amount of financial assets
Debt instruments measured at amortised cost 1,104,767 1,025,118
Carrying amount of financial liabilities
Measured at amortised cost 115,463 248,114

Financial assets measured at amortised cost comprise cash at bank, trade debtors and amounts owed to companies.

Financial liabilities measured at amortised cost comprise trade creditors, other creditors, other taxation and social security and accruals.

12
Debtors
Group
Amounts falling due within one year:
Trade debtors
Other debtors
Prepayments and accrued income
12.1 Debtors
Company
Amounts falling due within one year:
Trade debtors
Amounts owed to Group Undertakings
Other Debtors
Prepayments		 2021
£
24,598
-
9,791
34,389
2021
£
12,192
165,568
-
9,789
187,549		 2020
£
44,389
-
18,871
63,260
2020
£
664
249,749
-
18,871
269,284

28

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

13 Creditors: amounts falling due within one year

Group
Other taxation and social security
Trade creditors
Other creditors
Accruals
Deferred income


13.1 Company

Other taxation and social security
Trade creditors
Accruals
Other creditors		 2021
£

28,277
39,366
2,026
103,314
33,442
206,425
2021

£
22,832
32,198

58,407
2,026
115,463
 2020
£
44,504
122,805
2,994
157,190
21,170
348,663



2020
£
35,780
113,340
96,000
2,994
248,114

14 Summary of funds – current year

Balance at 1
April 2020
£
General
unrestricted
funds
Restricted
Funds
737,745
-
Total Funds
737,745		 Income
£
1,251,247
140,000
1,391,247		 Expenditure
Balance at 31 March
2021
£
£
(1,021,758)
(100,000)
967,234
40,000
1,112,758
1,007,234		 Expenditure
Balance at 31 March
2021
£
£
(1,021,758)
(100,000)
967,234
40,000
1,112,758
1,007,234
1,007,234

Restricted funds are those held for specific purposes, as specified by the funder, as defined in the accounting policies. All restricted fund balances relate to one fund from Iceland to support our Sepsis Savvy Campaign.

14.1 Summary of funds – prior year

Balance at 1 Income Expenditure Balance at 31 March
April 2019 2020
£ £ £ £
General 532,795 2,407,944 (2,202,994) 737,745
unrestricted
funds

There were no restricted funds in the prior year.

29

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

15 Analysis of net assets between funds

Unrestricted
funds
Restricted
Funds
Total
2021
2021
2021
£
£
£
Fund Balances
Tangible Assets
4,748
-
4,748
Current Assets
1,168,911
40,000
1208,911
Current Liabilities
(206,425)
-
(206,425)
967,234
40,000
1,007,234
There were no restricted fund balances in 2020.
16
Deferred income
Group and Charity
2021

£
Deferred income bought forward
21,170
Resources deferred during the year
16,775
Amounts released from previous years
(4,503)
33,442		 Total
2020
£
10,913
1075.495
(348,663)		 Total
2020
£
10,913
1075.495
(348,663)
737,745
2020
£
13,232
21,171
(13,232)
21,170

Deferred income comprises of course fees paid for in advance along with Law partner contracts which complete in August 2021.

17 Retirement benefit schemes

Defined contribution schemes

The group operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

The charge to financial activities in respect of defined contribution schemes was £15,066 (2020 - £18,806). The outstanding liability at year end was £1,013 (2020 - £1,497).

18 Operating lease commitments

At the reporting end date the charity had no outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Amounts payable:
Within one year
Between two and five years		 2021
£
-
-
-		 2020
£
40,639
14,434
55,073

30

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

19 Related party transactions

The charity has taken advantage of the exemptions under FRS 102 S33.1a, not to disclose transactions with wholly owned subsidiaries and companies in the same group with 100% ownership.

Dr Darren Daniels is also a director of Global Sepsis Alliance Limited. During the year 2021, the Group paid subscription fees to Global Sepsis Alliance Limited of £Nil (2020: £387).

Magnetic HCA Limited is related to Sarah Hamilton-Fairley by virtue of a family relationship. During the year, the group engaged the provision of various IT and marketing services of Magnetic HCA Limited and was charged £20,517 (2020: £23,358) for such services. Due to the related party Sarah Hamilton-Fairley was excluded from any decision to engage with the supplier.

20 Controlling party

The control of the charity rests with the trustees and executive team collectively.

21 Subsidiaries

Details of the charity's subsidiaries at 31 March 2021 are as follows:

Name of undertaking Registered Nature of business Class of % Held
office shares held Direct Indirect
Sepsis Enterprises Limited First Floor Fundraising events Ordinary 100
International shares
House,
Heatherton
Street, Walsall
WS4 2LA

During the year ended 31 March 2021 Sepsis Enterprises Limited reported income of £78,331 (2020 - £436,204) And expenditure of £5,928 (2020 - £271,879.

31

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarantee)

FOR THE YEAR ENDED 31 MARCH 2021

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

22
Cash generated from operations
2021
£
Net income for the year (as per Statement of Financial Activities)
269,489
Adjustments for:
Loss on disposal of tangible fixed assets
-
Depreciation and impairment of tangible fixed assets
6,165
Movements in working capital:
(Increase)/Decrease in debtors
28,871

Increase/(Decrease) in creditors
(154,511)
Increase in deferred income
12,273
Increase in provision for R&D Tax reclaim
-
Cash generated from operations
162,287		 2020
£
204,950
-
8,116
23,397
211,960
7,938
(6,258)
450,103

22 Post Balance Sheet Events

Business operations were impacted from approximately March 2020 onwards due to the COVID-19 pandemic; an event which has continued after the balance sheet date. The Charity was able to draw on previously prepared pandemic and crisis plans, which were implemented accordingly. During this period, the Charity took all necessary measures to protect the business and maintain operations as much as possible. Despite the impact of COVID-19, the directors believe that the Charity can meet its obligations as they fall due for a period of at least 12 months from the date of approval of these financial statements.

32